NeuroVive proposes rights offering

NeuroVive Pharmaceutical AB (SSE:NVP), Lund, Sweden Business: Neurology Date announced: 1/8/14 Type: Rights offering To be raised: Up to SEK75.8 million ($11.6 million) Shares: 5.4 million Price: SEK1...